Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:January 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:January 5, 2024Recruiting
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:October 12, 2021Unknown status
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:June 18, 2023Completed
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:December 20, 2021Completed
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:April 6, 2022Completed
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:February 4, 2022Completed
Condition(s):Candidiasis, Vulvovaginal; Recurrent Candidiasis of VaginaLast Updated:May 17, 2023Recruiting
Condition(s):Candidiasis, Vulvovaginal; Recurrent Candidiasis of VaginaLast Updated:November 12, 2020Not yet recruiting
Condition(s):Recurrent Vulvovaginal CandidiasisLast Updated:May 6, 2023Recruiting
Condition(s):Vulvovaginal Candidiasis, Genital; Laser TherapyLast Updated:March 11, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.